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Introduction 
 
The etiology of periodontal diseases has been associated with microorganisms 
colonizing the subgingival biofilm.¹ Among these, Aggregatibacter 
actinomycetemcomitans has received particular attention and it is regarded a major 
pathogen, being a key factor in the etiology of early onset and refractory forms of 
periodontitis. ¹⁻⁴	  This notion is derived primarily from association studies, conducted in 
North America and Europe, which significantly correlated the presence and amount of 
these microorganisms with the presence and severity of disease and also linked a worse 
than expected treatment outcome with presence of high levels of A. 
actinomycetemcomitans after therapy. In prospective studies, its presence has also been 
identified as a risk factor for the onset of periodontitis.⁵ On the other hand, A. 
actinomycetemcomitans has also been frequently detected in subjects without clinical 
evidence of periodontal disease, what suggests that either not all subjects are equally 
susceptible or that there are variations in the virulence and the pathogenic potential of 
this microorganism.	  
  
Based on the presence of specific capsular proteins able to elicit a subject’s 
differential antibody response, six serotypes (from “a” to “f”) of A. 
actinomycetemcomitans have been identified.⁶ This genetic variability has been 
associated to differential virulence since A. actinomycetemcomitans serotype “b” has 
been linked to periodontitis lesions, while serotypes “a” and “c” demonstrated a 
stronger association with periodontal health.²	   ⁷⁻⁹ A similar serotype-dependent 
differential virulence has also been suggested for Porphyromonas gingivalis. ¹⁰  ̛¹¹ 
  
The global A. actinomycetemcomitans serotype distribution is not homogeneous  
and the association between serotype and periodontal status may depend on the 
geographical location and/or ethnicity of the studied population.	  ¹²⁻¹⁵	  For example, Yang 
(2004) found that serotype “b” was more often isolated in aggressive than chronic forms 
of periodontitis in a large population in Philadelphia.¹⁶ Although most studies suggest 
that A. actinomycetemcomitans colonization occurs through one unique serotype, others  
have shown infected  subjects with two or three serotypes.⁷ ̛ ¹⁷⁻²⁰ 
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A. actinomycetemcomitans has also demonstrated other forms of genetic 
diversity also linked to virulence traits, mostly in relation to its capacity to produce 
leukotoxin, a protein that specifically destroys human polymorphonuclear leukocytes. 
²¹⁻²³	   There are, however, significant variations in the leukotoxin production 
demonstrated among different isolates.¹⁰  ̛²³ The mechanism by which the most virulent 
species produce high levels of leukotoxin was identified by a 530-bp deletion in the 
region upstream of the leukotoxin gene operon (lxt), which encodes this protein, thus 
bringing a second strong promoter and producing high amounts of this toxin. The 
majority of strains of this highly leukotoxic clone were isolated from subjects of 
African descent. Haubek et al. demonstrated, in a population based longitudinal study of 
700 adolescents, that the JP2 strain of A. actinomycetemcomitans was the etiological 
agent of the aggressive forms of periodontitis in adolescents living in or originating 
from North and West Africa.²⁴	   Individuals who carried the JP2 clone of A. 
actinomycetemcomitans had a significantly increased risk of periodontal attachment 
loss, either alone (relative risk 18.0) or together with the presence of non-JP2 clones of 
A. actinomycetemcomitans (12.4). A much less pronounced disease risk was found in 
those carrying non-JP2 clones only (3.0). 
 
Another identified virulence factor associated to this bacterial species is the 
cytolethal distending toxin (Cdt), which blocks the progression of the cell cycle in 
specific types of eukaryotic cells and other cell lines, specifically oral epithelial cells 
and T lymphocytes. This holotoxin, which has only been identified in A. 
actinomycetemcomitans isolated from the human oral cavity is made up of three subunit 
proteins designated as CdtA, CdtB and CdtC and different studies have reported that 
this cytotoxic Cdt activity is also heterogeneous among A. actinomycetemcomitans 
isolates. In a study by Ahmed et al, 86% of A. actinomycetemcomitans isolates 
presented the complete operon and its characteristic cytotoxic activity.²⁵	̛   ²⁶ Tan et al. 
showed a close association between aggressive forms of periodontitis and A. 
actinomycetemcomitans strains positive to the Cdt genotype. ²⁷ 
 
In summary, numerous studies have shown that the genetic diversity in A. 
actinomycetemcomitans strains may be associated to geographical diversity, thus 
suggesting a differential virulence.⁷	   ⁹ ̛ ²¹	   ²⁸	̛   ³²	   Since there are no studies in Southern 
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Europe evaluating the differential virulence of A. actinomycetemcomitans isolates in 
periodontitis patients, it is the objective of this investigation to study the serotype 
distribution of A. actinomycetemcomitans, the variation in the sequences of the genes 
that codify the leukotoxin and the distribution of the cdt operon in periodontitis patients 
in Spain. 
 
 
Material and methods 
 
Patient selection and sample reception  
The bacterial isolates used in this study were obtained from a consecutive series of 
subgingival microbial samples from Spanish patients sent to the Laboratory of 
Microbiology at Faculty of Odontology, University Complutense, Madrid, Spain, for 
microbial diagnosis over 18 months from January 2007 to July 2008. The patient 
residence was Spain and ethnicity Caucasian in all cases. All samples were taken from 
patients as part of their periodontal diagnostic process, and they were informed about 
the benefits of the microbiological diagnosis, an overview of the microbiological 
procedures and that, eventually, some of the cultured colonies could be isolated for 
further processes, including definitive identification. Verbal consent was obtained from 
all patients. 
 
Samples from patients with a clinical diagnosis of chronic or aggressive 
untreated periodontitis according to the American Academy of Periodontology 1999 
classification were included.³³ Sample from patients categorized as “refractory” 
periodontitis as a separate group were also included, when these subjects had a 
recurrence of disease after treatment or when the treatment outcome was not 
appropriate.  
 
These microbiological samples were collected by periodontists in private 
practices as well as by postgraduate students in the Postgraduate Clinic of 
Periodontology in the same Faculty of Odontology. Each sample was accompanied by 
clinical information including patient age, gender, clinical diagnosis, brief clinical and 
drug intake history, smoking status, sample sites and time and date of sampling. The 
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clinical parameters: probing pocket depth (PPD), gingival recession, presence or 
absence of plaque (PI), bleeding on probing (BOP) and suppuration were recorded at 
the four selected sites from which samples were taken. These sites represented the 
deepest pocket with bleeding in each quadrant and after careful removal of 
supragingival plaque and isolation with sterile cotton rolls and gentle air drying, two 
consecutive sterile paper points (medium size, Maillefer, Ballaigues, Switzerland) were 
inserted as deep as possible in the pocket, and left in place for 10 seconds. ³⁴ The paper 
points were transferred to a vial containing 1.5 ml of Reduced Transport Fluid (RTF), 
and pooled with all the other paper points.³⁵ The vial was sent to the laboratory and 
processed within 24 hours.  
 
Only samples were selected when belonging to patients with at least four sites 
with (PPD) deeper than 4 mm and clinical attachment loss (CAL) higher than 4 mm. 
Samples from subjects with fewer than 16 teeth and from patients who had taken any 
antibiotic medication within the previous three months were excluded.  
 
Culture, isolation and storage  
Samples were homogenized with a vortex and 10-fold serially diluted in Phosphate 
sodium buffer (PBS) and aliquots of 100 µl were plated in two different media: Blood 
agar medium (No. 2 of Oxoid; Oxoid Ltd., Basingstoke, England), with 5% horse 
blood, and haemin (5 mg/l) and menadione (1 mg/l) and Dentaid-1 medium.³⁶ 
 
Blood agar plates were studied after 7 and 14 days of anaerobic incubation (80% 
N2; 10% H2; 10% CO2 at 37ºC). Plates were carefully examined and based on the 
morphology of the isolated colonies the following pathogens were identified: P. 
gingivalis, Prevotella intermedia/nigrescens, Tannerella forsythia, Parvimonas micra, 
Capnocytophaga spp., Eikenella corrodens and Fusobacterium spp. Colonies from each 
pathogen were counted as the total number from  a representative plate (between 30 to 
300 colonies). The specific media, Dentaid-1 was used for the selective isolation and 
growth of A. actinomycetemcomitans. Plaques with this media were incubated at 37ºC 
in air with 5% CO2 and after 3-5 days were carefully examined for the identification of 
A. actinomycetemcomitans. This identification was based on its typical colony 
morphology, a catalase reaction and a set of specific enzymes (Rapid ID, NH system 
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Romel Inc, USA). One to three isolates per subject were subcultured and purified. All 
original samples were stored at -80º until further use. Only positive isolates for A. 
actinomycetemcomitans were included in this investigation. 
 
Isolation of genomic DNA 
Bacterial cells were collected after centrifugation and re-suspension in 1 ml of tris- HCl 
10 mM, EDTA 0.8 mM (ph 8.0) and lysozyme (final concentration 5.0 mg/ml). They 
were then incubated at 37 ºC for 30 min and proteinase K was added until reaching a 
final concentration of 2 mg/µl, 1 mg/µl and 1 %, respectively. ³⁷ The DNA was then 
extracted with equal volumes of phenol (saturated with 10 mM Tris-HCl, pH 8.0) and 
phenol- chloroform-isoamyl alcohol (25:24:1). Bulk nucleic acids were precipitated 
from the solution using ethanol followed by centrifugation (12.000 rpm) for 10 min. 
The DNA precipitate was re-suspended in 50 µl of sterile distilled water. The result of 
the DNA extraction was assessed by electrophoresis. A 5 µl aliquot of extracted DNA 
was electrophoresed through a 1.0 % agarose gel, in a tris- Acetate EDTA (TAE) buffer. 
The gel was stained with ethidium bromide (10 µg/ml) and visualized under UV-
illumination. 
 
Serotyping of strains 
Serotypes “a” to “f” were determined by the PCR technique, based on specific 
sequences from the gene clusters responsible for the distinct serotypes. The PCR 
reaction was performed with the specific primers described by Kaplan for the 
identification of the serotypes “a” to “f”. ⁶ The sequences of the primers used are listed 
in Table 1. The PCR reaction was performed in a 25 µl final volume containing 2.5 µl 
of 10x PCR buffer, 1.0 µl of 25mM MgCl2, 0.5 µl of 10 mM deoxynucleoside 
triphosphates, 0.5 U Taq DNA polymerase (Invitrogen Corporation, CA, USA), 1.0 µl 
of 25 µM primers and 2 µl of genomic DNA. A 15 µl aliquot of each PCR is 
electrophoresed through a 1.0 % agarose gel in 1X TAE buffer, the PCR products are 
visualized by staining with ethidium bromide (10 mg/ml) and visualized under UV 
illumination. These PCR assays were performed including positive and negative 
controls in an iCycler Thermal Cycler (Bio-Rad Laboratories, Inc). After the initial step 
of denaturation at 96 ºC for 3 min, a total of 35 PCR cycles were performed; each cycle 
consisted of 30 s of denaturation at 95 ºC, 1min of annealing at 55 ºC and 72ºC for 2 
min, and a final step of extension at 72 ºC for 10 min. 
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Detection of putative leukotoxin overproducers 
The deletion of 530 bp in the promoter region of the leukotoxin gene was determined in 
every isolate by means of PCR. The PCR primers and conditions for detecting the JP2 
strain were those described by Haubek et al. ³⁰	  The PCR reaction was performed in a 25 
µl final volume containing 2.5 µl of 10x PCR buffer, 1.0 µl of 25mM MgCl2, 0.5 µl of 
10 mM deoxynucleoside triphosphates, 0.5 U Taq DNA polymerase (Invitrogen 
Corporation, CA, USA), 1.0 µl of 25 µM primers and 2 µl of genomic DNA. 
 
PCR primer upstream from the deletion had the sequence 5´-
CAGATCAAAACCTGATAACAGTATT-3´, and the primer downstream from the 
deletion had the sequence 5´TTTCTCCATATTCCCTCCTTCTGT-3´.The PCR 
temperature profile included an initial step of denaturation at 94 ºC, a total of 30 cycles 
of denaturation for 1 min at 94ºC, annealing for 1 min at 60ºC, and a final step of 
extension at 72ºC for 2 min. The PCR fragment of 504 bp indicated deletion of 530 bp 
corresponding to the JP2 strain whereas a PCR fragment of 1034 bp indicated no 
deletion in the A. actinomycetemcomitans leukotoxin operon. Positive and negative 
controls were included in the PCR. The molecular weights of the PCR products were 
determined by visualization and comparison with standard molecular weight markers 
using agarose gel electrophoresis. 
 
 cdt detection  
The distribution of the cdt operon was also determined by means of PCR using the same 
procedure previously described for Ltx but using the primers that amplify the complete 
operon cdtA1 and cdtC2, which are listed in Table 2. The total molecular weight of the 
amplified segment was of 2016 bp when the complete operon was present. The PCR 
products were also determined by visualization in 1.0 % agarose gel.  
 
Data analyses 
Descriptive statistics, including frequency distribution were used to characterize the 
sample in terms of the different serotypes, the variation in the sequences of the genes 
that codify the leukotoxin and the distribution of the cdt operon. Further subgroup 
analysis was performed to assess the differences in serotype, leukotoxin and cdt gene 
over-production according to the different clinical diagnoses: chronic, aggressive or 
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refractory, as well to other clinical and patient variables. 
 
For continuous variables, ANOVA test was used to compare different disease 
categories, with the multiple rank test as the post hoc test. For categorical variables, 
contingency tables were constructed and compared by means of chi-square test. The 
software used for the analyses was Statgraphics Plus 5.1 (Statpoint Technologies, Inc., 
Warrenton, VA, USA). 
 
 
Results 
 
Demographics 
 
From a total of 701 patient samples processed, 396 samples were taken in 25 private 
practices throughout Spain (16 were located in Madrid area), and 305 from patients 
seeking treatment in the Section of Periodontology, Faculty of Odontology, University 
Complutense, Madrid, Spain. Out of these 701 patients, 40 (5.7%) fulfilled the inclusion 
criteria and were positive for A. actinomycetemcomitans. These patients had a mean age 
of 45.2 years (ranging 24-68) and were predominantly non-smokers 62.5% (25). They 
were stratified in three groups according to their periodontal condition and 19 (47.5%) 
were diagnosed of chronic periodontitis, 13 (32.5%) of aggressive periodontitis and 8 
(20%) of “refractory” periodontitis. “Refractory” periodontitis patients had significantly 
more recession (p=0.010) and shallower pockets (tendency towards statistical 
significance, p=0.051) than chronic and aggressive periodontitis patients. Similar CAL 
levels (7.5-7.7 mm), BOP proportions (78-85%) and plaque index (40-45%) were 
observed among the three patient groups. Patients with aggressive periodontitis were 
significantly younger (p<0.001) than chronic periodontitis or refractory patients. The 
detailed periodontal status, clinical and demographic variables of these 40 patients are 
depicted in Table 3. No differences among the three groups were observed for either 
smoking or gender (Table 4).  
 
Patient-based results 
 
Serotype distribution (Table 4) 
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Overall, 75% of the patients were characterized by a unique serotype, while 17.5% 
harbored two serotypes and in 7.5% of the patients the serotype could not be 
characterized (although A. actinomycetemcomitans was confirmed by PCR using 
different primers). In the patients where a unique serotype was identified, “a” or “b” 
serotypes were detected in 60% of the patients, while in those patients with more than 
one serotype, 4 different co-colonization profiles were detected, with 1-3 patients each. 
 
When assessing the serotype distribution according to clinical diagnosis, 
refractory patients showed a clear predominance of serotype “b” (either alone in 50% of 
the cases, or combined with serotype “a” in 25% of the patients) and the frequent 
presence of more than one serotype (37.5%). In aggressive periodontitis, mono-
colonization with “a” and “b” serotypes occurred in 25% and 35% of the cases, 
respectively. A less clear pattern was observed for chronic periodontitis, with similar 
figures for serotypes “a”, “b”, “c”, not-typeable and co-colonization. 
 
cdt operon detection (Table 4) 
Cdt positive samples were identified four times more frequently. Presence of Cdt 
positive and negative isolates in the same patient was observed in 28% of the cases. No 
Cdt negative samples were observed in refractory patients, while in chronic 
periodontitis there was also a clear predominance of Cdt positive profiles (67%). 
 
 
lktC promoter deletion  
No highly leukotoxic JP2 strains (identified by the presence of a 530-bp deletion in the 
promoter region of the lktC gene of A. actinomycetemcomitans) were identified in this 
studied population. In all the isolates, a clear band in the 1.0 % agarose gel, equivalent 
to a molecular weight of 1034-bp was observed. 
 
Strain-based results 
From the 40 positive samples, 79 strains were isolated and studied corresponding to 
serotype “a”, 24 strains (30.4%), to serotype “b”, 30 strains (38%), to serotype “c”, 12 
samples (15.2%) and to serotype “d”, 4 samples (5.1%). Mono-colonizations with 
serotypes “e” or “f” were not identified and the serotype could not be determined in 9 of 
these strains (11.4%). All strains were positive for the ltx gen. The cdt gene was 
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detected in 52 out of the 79 strains of periodontitis patients (65.8%). 
 
The distribution of the cdt gen among different serotypes (Table 6) showed a 
clear predominance of cdt positive strains in serotype “a” and, to a lesser extent, in 
serotype “c”, while an almost even distribution was observed for serotypes “b” and “d”. 
The differences between serotypes “a” and “b” were statistically significant (p=0.042). 
 
 
Discussion 
 
The main findings of this investigation show that among the 40 patients where A. 
actinomycetemcomitans was detected 75% carried a unique serotype, while 17.5% were 
colonized by two serotypes. The most predominant serotypes were “a” and “b” and 
none of the isolates were highly leukotoxic strain JP2 and while 65.8% were positive 
for the cdt gen.  
 
Using bacterial culturing the obtained prevalence of A. actinomycetemcomitans 
in this adult periodontitis population from Spain was of 5.7%. Previous reports from our 
research group have shown similar prevalence data using culture (6.3%) in a similar 
Spanish population, although using PCR methods the prevalence rose to 18.8%.³⁸ A 
similar low prevalence (3.2%) was also reported when studying a comparable 
population in Spain, but with the use of different culture medium (TSVB Tryptic soy-
serum- bacitracin-vancomycin),³⁹ also reporting a low recovery rate.³⁶ In other 
geographical locations, the reported prevalence of A. actinomycetemcomitans in 
periodontitis patients varies substantially depending on the microbial detection 
technologies used, with proportions ranging between 3% to 38% in United States of 
America and 15% in Sri Lanka when using immunofluorescence.³⁷⁻⁴⁰ With the use of 
bacterial culturing the reported prevalence of A. actinomycetemcomitans has varied 
between 5.4% in a group of aggressive periodontitis patients in Jamaica to 18% in 
Germany  or 54.4% in Ghana.⁴¹⁻⁴³ These prevalence can rise to 83% in China and to 
93% in Thailand when using DNA-DNA checkerboard hybridization.⁴⁴⁻⁴⁵ With  PCR 
the reported prevalence was 23.5% in United States of America, 19% in a Thai 
population, between 17.5% and 25% in Brazil, from 30%  to 47.7% in Germany, 26.7% 
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in Korea, 27.5% in a Greek population  and 44% in Haiti.⁴²	  	  ⁴⁶⁻⁵³	  	  	  
 
From the 40 A. actinomycetemcomitans-positive samples studied, 79 strains 
were isolated and studied, being the serotype “b” the most frequent, followed by 
serotype “a”, both representing 68.4% of all the strains. These findings are in 
accordance with other studies assessing populations from different geographical 
locations, which have also reported predominance in A. actinomycetemcomitans 
serotypes “a”, “b”, and “c”, including Germany.	   ⁵⁴ In the United States of America, 
serotype “b” strains were more frequently isolated from patients with localized juvenile 
periodontitis (LJP) when compared to other periodontal conditions or periodontally 
healthy subjects. ⁷	̛   ⁹ Listgarten et al. reported that elevated antibody responses to 
serotype “a” were more common in chronic periodontitis patients.	   ⁵⁵ In this 
investigation, we have identified not only a higher percentage of serotype “a” strains in 
chronic periodontitis patients, but also in aggressive periodontitis patients, in which the 
most common is the serotype “b”, like in the refractory periodontitis group. On the 
contrary, Dogan et al. reported that serotype “a” was the most frequent serotype in LJP 
subjects while in adult periodontitis subjects no differences among the serotypes “a”, 
“b” and “c” were reported.⁵⁶ A higher frequency of serotype “b” was reported in 
Finnish patients with periodontitis, while “c” was more often related to periodontally 
healthy subjects.	  ⁹ ̛²⁰	  In Asian populations, such as in Korea and Japan or in European 
countries, such as in Greece, the serotype “c” was also frequently associated with 
periodontally affected sites. ¹⁹ ̛²⁰	̛  ⁵²	  ⁵⁷	  Strains with serotypes “d”, “e” and strains without 
detectable serotype were also identified in Japanese subjects in proportions of 5%, 23% 
and 10%, respectively. ¹⁸	̛  ⁵⁶	  These serotypes are less frequently found than “a”, “b” and 
“c” serotypes.¹⁰ ̛ ¹⁷ ̛¹⁸ ̛⁵⁶	  	  ⁵⁸ 
 
This investigation demonstrated that the genes responsible for the codification of 
the Ltx were present in all the strains (100%), but none showed the JP2 clone 
responsible of the highly leukotoxic strains. These highly virulent A. 
actinomycetemcomitans strains have been detected mainly in subjects of African origin, 
with proportions of 8.8% reported in Ghana adolescents and 77% in Moroccan patients 
with a diagnosis of aggressive periodontitis and with a higher risk of periodontal 
attachment loss.⁴³	   ⁵⁹ JP2 clone strains have also been reported in other distant 
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geographical populations, such as in Thailand, but has been found to be absent in 
Greece.⁴⁷ ̛ ⁵¹ In a German population, and using PCR, the JP2 clone was found to be 
present in 2 out of 99 (2%) of the recruited patients and, in both cases, the subjects were 
immigrants of African origin suffering from chronic periodontitis.⁵⁴ Using a 
characterization method of point mutations within housekeeping genes and 
pseudogenes, Haubek et al. developed a model of global spreading of the JP2 clone. ⁶⁰ 
According to this model, the patterns of mutation suggest that the JP2 clone emerged 
from a distinct genotype in the Mediterranean Africa approximately 2400 years ago and 
spread subsequently to West Africa and to other parts of the world. In fact, in Brazil 
colonization by highly leukotoxic A. actinomycetemcomitans was associated with 
increased periodontitis severity.³⁸ Even though JP2 clone strains have almost been 
exclusively detected among individuals in North-Africa or from African descent limited 
information is still available regarding the microbiological status of this clone in 
Caucasians. In fact, this study has shown that a Spanish population, although being in 
close relation to North African populations (namely, Moroccan populations), due to 
geographical and immigration factors, did not harbor any highly leukotoxic strains. 
 
This investigation also evaluated the third factor of genetic variability of A. 
actinomycetemcomitans, the cdt gene, being detected in 65.8% of the strains from 
periodontitis patients. The reported prevalence of this toxin in A. 
actinomycetemcomitans strains is highly variable. It has been found to be present in 
45.5% of a chronic periodontitis patient sample in Germany.	  ⁵⁴ Ahmed et al. found 43 
of 50 strains from periodontitis patients contained all three cdt genes and expressed Cdt 
activity. ²⁶ Similarly, Fabris et al. reported Cdt activity in 39 out of 40 patients.⁶¹ In 
another study, however, only 13 out of 106 diseased sites were positive for these 
genes.²⁸ 
 
It is important to highlight the limitations of the present observational study, 
since a limited number of strains were studied and due to the low prevalence of A. 
actinomycetemcomitans in Spanish periodontitis patients the obtained associations only 
allowed us to generate hypothesis, rather than to establish clear conclusions. Moreover, 
in 22.5% of the patients, only one strain was studied and therefore, the results from the 
co-colonization of different strains per patient should be taken with caution. Similarly in 
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a small number of patients, strains with non-attributable serotype were identified, which 
may belong to the serotype e´ described by van der Reijden et al., since we did not use 
this specific primer, that was described after our samples were analyzed.⁶² Furthermore, 
the stratification used according to the patient’s clinical diagnosis should also be taken 
with caution since different clinicians, not using uniform criteria, did the diagnosis. In 
spite of this, the study showed the high variability in the genetic variance of A. 
actinomycetemcomitans, which has been also reported in similar studies. This 
variability may be explained, in part, by the different bacterial detection techniques used 
in the different laboratories, but also due to differences in ethnicity, geographic location 
and the periodontal condition of the populations sampled. Further studies should 
evaluate whether the presence of certain pathogenic bacterial species is associated with 
periodontitis and attachment loss in some population groups but not in others, 
depending on the presence of specific virulence traits. 
 
In conclusion, this research has evidenced that, in samples from a group of 
Spanish patients with periodontitis, the most common A. actinomycetemcomitans 
serotypes found were “b” and “a”, while “e” and “f” were not detected. The genes 
responsible for the codification of leukotoxin were detected in all the strains, although 
none belonging to the JP2 strain. The operon that codifies the cdt was also detected in 
the majority of the samples (65.8%).  
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